Clinical Trial Detail

NCT ID NCT01213238
Title Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Oxaliplatin

Capecitabine

Bevacizumab

Age Groups: adult senior

No variant requirements are available.